First Deuterated Drug Approved
In April, the US Food and Drug Administration cleared the first deuterated drug, Austedo (deutetrabenazine), from Teva of Petach Tikva, Israel, for the treatment of Huntington’sdisease-related movement disorders.
Archives
Children With Cancer Get More Access to Experimental Drugs
New U.S. law will require pediatric cancer clinic trials.
U.S. Preventive Services Task Force Confronts Critics
In May, the U.S. Preventive Services Task Force recommended against screening for thyroid cancer. After reviewing the available evidence, the task force concluded…
Why the FDA Wants More Control Over Some Lab Tests
The FDA finds that many so-called laboratory-derived tests may actually harm patients.
Breaking the Mold: New Strategies for Fighting Aflatoxins
Pervasive in the developing world, moldy crops threaten millions with cancer and other illnesses.
New Guidelines Allow Some Patients With Chronic Myeloid Leukemia To Go Off Treatment
Most patients with chronic myeloid leukemia (CML) can live out their normal lives by taking tyrosine kinase inhibitors (TKIs). But mounting evidence also shows that roughly a third of those patients can eventually go off treatment altogether without their disease resurging.